Patents by Inventor Michael H. Dealey

Michael H. Dealey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for administering steroid
    Patent number: 5897878
    Abstract: A dosage form is disclosed comprising means for lessening the tackiness and/or irritation of the components of the dosage form to mucosal tissue. The dosage form provides means for forming in the dosage form a floc comprising a drug, which floc, when delivered from the dosage form, lessens the tackiness and/or irritation of the mucosal tissue of a warm-blooded recipient.
    Type: Grant
    Filed: October 21, 1992
    Date of Patent: April 27, 1999
    Assignee: ALZA Corporation
    Inventors: Liang C. Dong, Michael H. Dealey, Terry L. Burkoth, Patrick S.-L. Wong, Jerry D. Childers, Brian L. Barclay
  • Dosage form comprising hydrophilic polymer
    Patent number: 5830501
    Abstract: A dosage form is disclosed comprising means for lessening the tackiness and/or irritation of the components of the dosage form to mucosal tissue. The dosage form provides means for forming in the dosage form a floc comprising a drug, which floc, when delivered from the dosage form, lessens the tackiness and/or irritation of the mucosal tissue of a warm-blooded recipient.
    Type: Grant
    Filed: October 21, 1992
    Date of Patent: November 3, 1998
    Assignee: ALZA Corporation
    Inventors: Liang C. Dong, Michael H. Dealey, Terry L. Burkoth, Patrick S. -L. Wong, Jerry D. Childers, Brian L. Barclay
  • Osmotic device with delayed activation of drug delivery and complete drug release
    Patent number: 5800422
    Abstract: The present invention is directed to a fluid-imbibing drug delivery device which is useful for the initial delayed delivery of an active agent formulation to a fluid environment of use, the initial delay period to startup or activation of the device being of a predetermined length of time. The delivery of the agent formulation from the dispensing device is continued until essentially all of the active agent formulation is delivered as a result of the expansion of an expansion agent in the active agent delivery chamber.
    Type: Grant
    Filed: August 8, 1996
    Date of Patent: September 1, 1998
    Assignee: Alza Corporation
    Inventors: Liang C. Dong, Patrick S.-L. Wong, Si-Hong A. Yum, Lawrence G. Hamel, Michael H. Dealey
  • Osmotic dosage system for liquid drug delivery
    Patent number: 5413572
    Abstract: An osmotic system is disclosed for delivering a beneficial agent formulation to an environment of use. The osmotic system comprises (a) an outside semipermeable wall, (b) a middle osmotically active layer, (c) a capsule comprising a beneficial agent, and (d) a passageway for dispensing the beneficial agent from the osmotic system.
    Type: Grant
    Filed: February 18, 1994
    Date of Patent: May 9, 1995
    Assignee: Alza Corporation
    Inventors: Patrick S. L. Wong, Felix Theeuwes, Brian L. Barclay, Michael H. Dealey
  • Method for administering drug
    Patent number: 5348746
    Abstract: A dosage form is disclosed comprising means for lessening the tackiness and/or irritation of the components of the dosage form to mucosal tissue. The dosage form provides means for forming in the dosage form a floc comprising a drug, which floc, when delivered from the dosage form, lessens the tackiness and/or irritation of the mucosal tissue of a warm-blooded recipient.
    Type: Grant
    Filed: October 21, 1992
    Date of Patent: September 20, 1994
    Assignee: Alza Corporation
    Inventors: Liang C. Dong, Michael H. Dealey, Terry L. Burkoth, Patrick S. L. Wong, Jerry D. Childers, Brian L. Barclay
  • Osmotic dosage system for delivering a formulation comprising liquid carrier and drug
    Patent number: 5324280
    Abstract: An osmotic system is disclosed for delivering a beneficial agent formulation to an environment of use. The osmotic system comprises (a) an outside semipermeable wall, (b) a middle osmotically active layer, (c) a capsule comprising a beneficial agent, and (d) a passageway for dispensing the beneficial agent from the osmotic system.
    Type: Grant
    Filed: April 2, 1990
    Date of Patent: June 28, 1994
    Assignee: Alza Corporation
    Inventors: Patrick S. L. Wong, Felix Theeuwes, Brian L. Barclay, Michael H. Dealey
  • Method for administering anti-Parkinson drug
    Patent number: 5266332
    Abstract: A dosage form is disclosed comprising means for lessening the tackiness and/or irritation of the components of the dosage form to mucosal tissue. The dosage form provides means for forming in the dosage form a floc comprising a drug, which floc, when delivered from the dosage form, lessens the tackiness and/or irritation of the mucosal tissue of a warm-blooded recipient.
    Type: Grant
    Filed: October 21, 1992
    Date of Patent: November 30, 1993
    Assignee: Alza Corporation
    Inventors: Liang C. Dong, Michael H. Dealey, Terry L. Burkoth, Patrick S.-L. Wong, Jerry D. Childers, Brian L. Barclay
  • Process for lessening irritation caused by drug
    Patent number: 5254349
    Abstract: A dosage form is disclosed comprising means for lessening the tackiness and/or irritation of the components of the dosage form to mucosal tissue. The dosage form provides means for forming in the dosage form a floc comprising a drug, which floc, when delivered from the dosage form, lessens the tackiness and/or irritation of the mucosal tissue of a warm-blooded recipient.
    Type: Grant
    Filed: October 21, 1992
    Date of Patent: October 19, 1993
    Assignee: ALZA Corporation
    Inventors: Liang C. Dong, Michael H. Dealey, Terry L. Burkoth, Patrick S. L. Wong, Jerry D. Childers, Brian L. Barclay
  • Process for improving dosage form delivery kinetics
    Patent number: 5200195
    Abstract: A dosage form is disclosed comprising means for lessening the tackiness and/or irritation of the components of the dosage form to mucosal tissue. The dosage form provides means for forming in the dosage form a floc comprising a drug, which floc, when delivered from the dosage form, lessens the tackiness and/or irritation of the mucosal tissue of a warm-blooded recipient.
    Type: Grant
    Filed: December 6, 1991
    Date of Patent: April 6, 1993
    Assignee: ALZA Corporation
    Inventors: Liang C. Dong, Michael H. Dealey, Terry L. Burkoth, Patrick S. L. Wong, Jerry D. Childers, Brian L. Barclay